Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

National Institute for Health and Care Excellence NICE logo

NICE gives final backing to drugs from Bayer, GSK and Otsuka

Eylea, Revolade and Abilify all recommended for NHS use

- PMLiVE

All eyes on pharma in Brazil

With a large population, a growing economy and a well-established healthcare system, Brazil is high on the list for most companies looking to expand into emerging markets.

- PMLiVE

Simbec appoints ex-ABPI DG as chairman

Trevor Jones move to the Wales-based CRO comes as Simbec receives a major cash boost

- PMLiVE

What next in home healthcare?

October conference will hear from Homecare Medicines Review author Mark Hackett and other key stakeholders

Biogen Idec building

Biogen Idec’s long-acting beta interferon moves ahead in MS

US and EU accept filings for long-acting multiple sclerosis drug Plegridy

- PMLiVE

UCB files Vimpat patent claims against 15 companies

Aurobindo, Glenmark, Mylan, Ranbaxy and Sandoz all face legal challenge over generic versions of UCB's epilepsy drug

China flag thumb

AstraZeneca and UCB drawn into Chinese investigations

Follows country’s clampdown on GSK bribery

- PMLiVE

Havas Lynx creates new med ed and scientific exchange agency

Will be known as Havas Lynx Medical

Sanofi Israel crowdsources new diabetes app

Collaborates with online patient network Camoni

- PMLiVE

Making mobile health technology work

Augmenting organic life with artificial technology is gaining ground in healthcare

- PMLiVE

NICE demands more data from Roche for MabThera in rare autoimmune disease

Unable to recommend expanding drug’s indication to include vasculitis

- PMLiVE

Infographic: Pharma investment in Indonesia

Pharma deals in the region since the introduction of Decree 1010 to force companies to manufacture products locally

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links